End-of-day quote
Shanghai S.E.
06:00:00 2024-05-30 pm EDT
|
5-day change
|
1st Jan Change
|
10.98
CNY
|
-2.14%
|
|
-5.10%
|
+7.75%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,613
|
2,842
|
5,613
|
6,531
|
5,187
|
5,589
|
-
|
-
|
Enterprise Value (EV)
1 |
2,613
|
2,842
|
5,613
|
6,531
|
5,187
|
5,589
|
5,589
|
5,589
|
P/E ratio
|
-
|
18.8
x
|
17.5
x
|
15.6
x
|
14
x
|
12.3
x
|
10
x
|
9.23
x
|
Yield
|
-
|
1.4%
|
1.67%
|
1.61%
|
1.8%
|
2.64%
|
3.1%
|
-
|
Capitalization / Revenue
|
1.87
x
|
2.22
x
|
1.88
x
|
1.85
x
|
1.4
x
|
1.33
x
|
1.14
x
|
0.95
x
|
EV / Revenue
|
1.87
x
|
2.22
x
|
1.88
x
|
1.85
x
|
1.4
x
|
1.33
x
|
1.14
x
|
0.95
x
|
EV / EBITDA
|
-
|
11.1
x
|
10.8
x
|
9.17
x
|
8.25
x
|
7.54
x
|
6.26
x
|
5.94
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
1.97
x
|
2.6
x
|
2.59
x
|
1.85
x
|
1.72
x
|
1.52
x
|
1.28
x
|
Nbr of stocks (in thousands)
|
431,200
|
431,200
|
508,416
|
509,016
|
509,016
|
509,016
|
-
|
-
|
Reference price
2 |
6.060
|
6.590
|
11.04
|
12.83
|
10.19
|
10.98
|
10.98
|
10.98
|
Announcement Date
|
4/28/20
|
3/29/21
|
4/21/22
|
3/30/23
|
4/9/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,395
|
1,278
|
2,993
|
3,534
|
3,699
|
4,202
|
4,904
|
5,858
|
EBITDA
1 |
-
|
255.1
|
520.6
|
712
|
628.9
|
741
|
892.7
|
941
|
EBIT
1 |
-
|
171.8
|
349.2
|
487.8
|
429.7
|
538
|
646.7
|
719
|
Operating Margin
|
-
|
13.44%
|
11.66%
|
13.8%
|
11.62%
|
12.8%
|
13.19%
|
12.27%
|
Earnings before Tax (EBT)
1 |
-
|
171.1
|
334.3
|
483.5
|
414.5
|
531
|
640.9
|
715
|
Net income
1 |
-
|
149.8
|
310.7
|
417
|
370.8
|
452
|
558
|
607
|
Net margin
|
-
|
11.72%
|
10.38%
|
11.8%
|
10.03%
|
10.76%
|
11.38%
|
10.36%
|
EPS
2 |
-
|
0.3500
|
0.6300
|
0.8200
|
0.7300
|
0.8900
|
1.095
|
1.190
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
0.0920
|
0.1840
|
0.2070
|
0.1830
|
0.2900
|
0.3400
|
-
|
Announcement Date
|
4/28/20
|
3/29/21
|
4/21/22
|
3/30/23
|
4/9/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
10.6%
|
15.7%
|
17.9%
|
14%
|
13.9%
|
15.2%
|
13.9%
|
ROA (Net income/ Total Assets)
|
-
|
8.57%
|
8.79%
|
10.5%
|
-
|
9.3%
|
11.5%
|
9.8%
|
Assets
1 |
-
|
1,749
|
3,533
|
3,981
|
-
|
4,860
|
4,869
|
6,194
|
Book Value Per Share
2 |
-
|
3.350
|
4.250
|
4.950
|
5.510
|
6.370
|
7.240
|
8.570
|
Cash Flow per Share
2 |
-
|
0.0200
|
0.8000
|
0.9600
|
0.7800
|
0.9800
|
1.160
|
1.110
|
Capex
1 |
-
|
96.8
|
327
|
256
|
291
|
286
|
255
|
235
|
Capex / Sales
|
-
|
7.57%
|
10.92%
|
7.25%
|
7.86%
|
6.81%
|
5.2%
|
4.01%
|
Announcement Date
|
4/28/20
|
3/29/21
|
4/21/22
|
3/30/23
|
4/9/24
|
-
|
-
|
-
|
Last Close Price
10.98
CNY Average target price
14.2
CNY Spread / Average Target +29.33% Consensus |
1st Jan change
|
Capi.
|
---|
| +7.75% | 772M | | +2.46% | 102B | | -8.98% | 60.79B | | +74.76% | 48.86B | | +13.97% | 37.96B | | +4.56% | 32.37B | | +14.72% | 20.64B | | +11.17% | 16.58B | | +8.81% | 13.93B | | -3.19% | 13.25B |
Other Commodity Chemicals
|